lamotrigine has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 is an autosomal dominant spinocerebellar degeneration, for which there is no effective treatment." | 6.71 | Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy. ( Cheng, WL; Hsieh, M; Hsu, HM; Liu, CS, 2005) |
| "Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 is an autosomal dominant spinocerebellar degeneration, for which there is no effective treatment." | 2.71 | Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy. ( Cheng, WL; Hsieh, M; Hsu, HM; Liu, CS, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CS | 1 |
| Hsu, HM | 1 |
| Cheng, WL | 1 |
| Hsieh, M | 1 |
1 trial available for lamotrigine and Autosomal Dominant Striatonigral Degeneration
| Article | Year |
|---|---|
Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy.
Topics: Adolescent; Adult; Anticonvulsants; Ataxin-3; Cell Line, Transformed; Dose-Response Relationship, Dr | 2005 |